Modulation of the respiratory burst in human neutrophils by isoproterenol and dibutyryl cyclic AMP

https://doi.org/10.1016/0165-5728(93)90075-AGet rights and content

Abstract

The effects of a β-adrenergic agonist and a cyclic AMP analogue on activation, activity, and termination of FMLP-stimulated superoxide anion production were investigated. Incubation with isoproterenol resulted in a 50% reduction in the maximal rate of superoxide production and a 3–4-fold increase in the rate of termination of superoxide production. Exposure to 1 mM dibutyryl cyclic AMP resulted in a 40% decrease in the maximal rate and a 3-fold increase in the rate of termination of FMLP-induced superoxide production. Neither agent had a significant effect on the lag time prior to superoxide anion generation.

References (32)

  • J.T. Curnette et al.

    Defect in pyridine-nucleotide dependent superoxide production by a particulate fraction from granulocytes of patients with chronic granulomatous disease

    New Engl. J. Med.

    (1975)
  • J.T. Curnette et al.

    Activation of the respiratory burst oxidase in a fully soluble system from human neutrophils

    J. Biol. Chem.

    (1987)
  • V. Della Bianca et al.

    Cyclic AMP inhibition of phosphoinositide turnover in human neutrophils

    Biochim. Biophys. Acta

    (1986)
  • E. Ernst et al.

    Leukocytes and risk of ischemic diseases

    J. Am. Med. Assoc.

    (1987)
  • G. Grynkiewicz et al.

    A new generation of Ca++ indicators with greatly improved fluorescence properties

    J. Biol. Chem.

    (1985)
  • S.J. Klebanoff

    Oxygen metabolism and the toxic properties of phagocytes

    Ann. Intern. Med.

    (1980)
  • Cited by (24)

    • Role of adrenergic receptor signalling in neuroimmune communication

      2021, Current Research in Immunology
      Citation Excerpt :

      Adrenaline also prevents stimulus-induced NET (neutrophil extracellular traps) formation, most probably through β-adrenergic receptor stimulation (Marino et al., 2018). β-adrenergic receptor activation in neutrophils is mainly attributed to the pathway involving cAMP and PKA (Bazzoni et al., 1991; Gibson-Berry et al., 1993; Marino et al., 2018). Expression of adrenergic receptor varies in different conditions such as in post-traumatic stage disorder leads to increase in expression of β-adrenergic receptor on neutrophils show higher β-adrenergic receptor (Gurguis et al., 1999), whereas its expression decreases in hypertension (Corradi et al., 1981), juvenile type 1 diabetes mellitus (Schwab et al., 1993), and strenuous physical exercise (Ratge et al., 1988; Schwab et al., 1993).

    • The role of neutrophils in neuro-immune modulation

      2020, Pharmacological Research
      Citation Excerpt :

      in vitro studies showed that βARs modulate neutrophil oxidative burst, chemotaxis, NET formation, and the expression of adhesion molecules, leukotriene B4 (LTB4), and chemokines/cytokines [62–65]. The intracellular βAR signaling, especially those associated with cAMP and PKA activation, modulate most to the neutrophil functions [66,67]. For example, isoproterenol, a β-adrenergic agonist, inhibits neutrophil oxidative burst induced by N-Formyl-methionyl-leucyl-phenylalanine (fMLP), a chemotactic peptide, or calcium ionophores by increasing intracellular calcium and cAMP levels [65].

    • Autonomic regulation of cellular immune function

      2014, Autonomic Neuroscience: Basic and Clinical
      Citation Excerpt :

      Activation of β2-ARs (in the nanomolar range of catecholamines) suppresses neutrophil chemotaxis to number of chemotactic factors (i.e., C5a, leukotriene B4, and formyl-methionyl-leucyl-phenylalanine) (Harvath et al., 1991), and at higher concentrations (~ 10− 5 M) suppresses phagocytosis (Zurier et al., 1974), lysosomal enzymes release (Zurier et al., 1974), and respiratory bursts that is linked to degranulation (Nielson, 1987; Weiss et al., 1996; Barnett et al., 1997). Catecholamines lower the rate of superoxide formation and shorten the time of release (Gibson-Berry et al., 1993). Similar effects of β-agonists on eosinophils are reported (Koyama et al., 1999).

    • Chiropractic management of a patient with myasthenia gravis and vertebral subluxations

      1999, Journal of Manipulative and Physiological Therapeutics
    View all citing articles on Scopus
    View full text